Related Experiment Video
Updated: Nov 18, 2025
Femoral Vascular Graft Implantation in a Swine Model to Test Small-Diameter Vascular Grafts
Published on: July 8, 2025
Ovine Biosynthetic Grafts for Aortoiliac Reconstructions in Nonsterile Operative Fields
Hazem El Beyrouti1, Mohammad Bashar Izzat2, Angela Kornberger1
1Department of Cardiothoracic and Vascular Surgery, Johannes Gutenberg University Hospital Mainz, Mainz, Rheinland-Pfalz, Germany.
Background:
Prosthetic vascular grafts placed surgically or via endovascular techniques can be subject to the risk of life-threatening graft infections. The Omniflow II vascular prosthesis is a biosynthetic graft that was reported to have favorable properties in resisting infections.
Materials And Methods:
We retrospectively reviewed our 3 years' experience of using the Omniflow II prostheses for aortoiliac reconstructions in patients considered to carry a substantial risk of subsequent prosthetic graft infections (prevention group) as well as in patients with actively infected prosthetic vascular grafts (treatment group).
Results:
Aorto-bi-iliac (n = 4) and aortobifemoral (n = 12) vascular reconstructions were performed using bifurcated Omniflow II prostheses in nine patients in the prevention group and seven patients in the treatment group. During mean follow-up of 28.6 ± 17.2 months, there was one case of graft infection (6.3%) and graft thrombosis (6.3%) with subsequent successful thrombectomy. Early and late surgical revisions were required in eight (50%) and two (12.6%) patients, respectively. All graft prostheses were patent at last follow-up.
Conclusion:
Using bifurcated Omniflow II vascular prostheses in patients with or at a high risk of vascular graft infection is advisable, and is associated with acceptable reinfection and patency rates.
